Renal Cancer - Results from #360

CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway. May 30, 2024

Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review. May 30, 2024

Preoperative Super-Selective Embolization versus "On-Clamp" Laparoscopic Partial Nephrectomy for T1 Renal Tumors- A Prospective Randomized Study. May 29, 2024

Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration. May 29, 2024

Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis. May 29, 2024

Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial. May 28, 2024

Targeting apoptosis in clear cell renal cell carcinoma. May 28, 2024

Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. May 27, 2024

Characterization of FOLH1 Expression in Renal Cell Carcinoma. May 27, 2024

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances. May 24, 2024

Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies. May 24, 2024

Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma. May 23, 2024

Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma. May 23, 2024

Native Kidney Renal Cell Carcinoma in Renal Allograft Transplant Patients - Our Experience. May 21, 2024

Fumarate Hydratase-Deficient Renal Cell Carcinoma with Nucleolar Pattern of GATA3 Immunoexpression: Report of 2 Cases. May 21, 2024

Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview. May 21, 2024

Serum IgA as a Prognostic Beacon: Anticipating Systemic Therapy Efficacy in Metastatic Clear Cell Renal Cell Carcinoma. May 21, 2024

The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. May 21, 2024

Comparison of lateral flank approach and low anterior access for single port (SP) retroperitoneal partial nephrectomy: an analysis from the single port advanced research consortium (SPARC). May 20, 2024

Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. May 20, 2024

Page 19 of 457